Literature DB >> 12198766

Protein expression profile of primary human squamous cell lung carcinomas indicative of the incidence of metastases.

Manfred Volm1, Reet Koomägi, Jürgen Mattern, Thomas Efferth.   

Abstract

The purpose of this investigation was to evaluate firstly whether different protein expression patterns exist in primary squamous cell lung carcinomas of patients with and without lymph node involvement and secondly, whether or not different patterns exist in tumours with positive lymph nodes. For this reason, formalin-fixed, paraffin-embedded specimens from 130 patients with squamous cell lung carcinomas were analyzed by immunohistochemistry. In a first step, proteins were selected which showed a relationship to lymph node involvement. The expression of JUN, ERBB2, MYC, cyclin D, PCNA, bFGF, VEGF and Hsp70 proteins revealed a positive correlation to lymph node involvement. In contrast, caspase-3, Fas ligand, Fas/CD95, and PAI showed an inverse correlation to lymph node involvement. In a second step, these parameters were further analyzed by hierarchical cluster analyses. The resulting clusters were correlated to patients with or without lymph node involvement. The data show that different protein expression patterns exist between primary squamous cell lung carcinomas with and without lymph node involvement and within carcinomas with lymph node involvement. The data suggest that various metastasis profiles exist.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12198766     DOI: 10.1023/a:1016361924216

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  24 in total

Review 1.  Cell biology of lymphatic metastasis. The potential role of c-erbB oncogene signalling.

Authors:  S A Eccles
Journal:  Recent Results Cancer Res       Date:  2000

2.  c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems.

Authors:  H Allgayer; R Babic; K U Gruetzner; A Tarabichi; F W Schildberg; M M Heiss
Journal:  J Clin Oncol       Date:  2000-06       Impact factor: 44.544

Review 3.  Angiogenesis and metastasis.

Authors:  L M Ellis; I J Fidler
Journal:  Eur J Cancer       Date:  1996-12       Impact factor: 9.162

Review 4.  Heat shock proteins in thermotolerance and other cellular processes.

Authors:  S W Carper; J J Duffy; E W Gerner
Journal:  Cancer Res       Date:  1987-10-15       Impact factor: 12.701

5.  Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck.

Authors:  R Michalides; N van Veelen; A Hart; B Loftus; E Wientjens; A Balm
Journal:  Cancer Res       Date:  1995-03-01       Impact factor: 12.701

6.  Telomerase activity and Bcl-2 expression in non-small cell lung cancer.

Authors:  Y Ohmura; M Aoe; A Andou; N Shimizu
Journal:  Clin Cancer Res       Date:  2000-08       Impact factor: 12.531

7.  Overexpression of the c-erbB-2/neu-encoded p185 protein in primary lung cancer.

Authors:  D Shi; G He; S Cao; W Pan; H Z Zhang; D Yu; M C Hung
Journal:  Mol Carcinog       Date:  1992       Impact factor: 4.784

8.  Tumor angiogenesis correlates with histologic type and metastasis in non-small-cell lung cancer.

Authors:  A Yuan; P C Yang; C J Yu; Y C Lee; Y T Yao; C L Chen; L N Lee; S H Kuo; K T Luh
Journal:  Am J Respir Crit Care Med       Date:  1995-12       Impact factor: 21.405

9.  Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression.

Authors:  L Holmgren; M S O'Reilly; J Folkman
Journal:  Nat Med       Date:  1995-02       Impact factor: 53.440

10.  A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer.

Authors:  R Michalides; P Hageman; H van Tinteren; L Houben; E Wientjens; R Klompmaker; J Peterse
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

View more
  4 in total

1.  Expression of caspase-3 and c-myc in non-small cell lung cancer.

Authors:  Jin young Yoo; Chi Hong Kim; So Hyang Song; Byoung Yong Shim; Youn Ju Jeong; Meyung Im Ahn; Suji Kim; Deog Gon Cho; Min Seop Jo; Kyu Do Cho; Hong Joo Cho; Seok Jin Kang; Hoon Kyo Kim
Journal:  Cancer Res Treat       Date:  2004-10-31       Impact factor: 4.679

2.  Role of serum vascular endothelial growth factor in the prediction of angiogenesis and prognosis for non-small cell lung cancer.

Authors:  Yuri Shimanuki; Kazuhisa Takahashi; Ri Cui; Satoshi Hori; Fumiyuki Takahashi; Hideaki Miyamoto; Yoshinosuke Fukurchi
Journal:  Lung       Date:  2005 Jan-Feb       Impact factor: 2.584

3.  Oxaliplatin-induced enteric neuronal loss and intestinal dysfunction is prevented by co-treatment with BGP-15.

Authors:  Rachel M McQuade; Vanesa Stojanovska; Rhian Stavely; Cara Timpani; Aaron C Petersen; Raquel Abalo; Joel C Bornstein; Emma Rybalka; Kulmira Nurgali
Journal:  Br J Pharmacol       Date:  2018-01-11       Impact factor: 8.739

4.  Serum proteome analysis for profiling protein markers associated with carcinogenesis and lymph node metastasis in nasopharyngeal carcinoma.

Authors:  Qiulin Liao; Liang Zhao; Xiaodong Chen; Yongjian Deng; Yanqing Ding
Journal:  Clin Exp Metastasis       Date:  2008-03-21       Impact factor: 5.150

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.